Código QR

Volume and Location Analysis of Intracerebral Hemorrhage for the Appropriate Use of Andexanet Alfa

Andexanet alfa was approved as a reversal agent for Factor Xa inhibitors in patients with uncontrolled or life-threatening bleeding, such as intracerebral hemorrhage. However, its use in cases of small hemorrhages remains controversial. This study determined the appropriate use of andexanet alfa on...

Descrición completa

Gardado en:
Principais autores: Takeru UMEMURA, Taketo HATANO, Yu ABEKURA, Takeshi MIYATA, Yuji AGAWA, Tomoya OGAWA, Takao MORITA, Wataru YOSHIZAKI, Takashi NAGAHORI, Koki MITANI, Ryo HAMAMOTO, Yusuke NAKAZAWA, Yukiko INAMORI, Wataru SHIRAISHI
Formato: Artigo
Idioma:Inglês
Publicado: The Japan Neurosurgical Society 2025-12-01
Series:Neurologia Medico-Chirurgica
Assuntos:
andexanet alfa
hematoma expansion
intracerebral hemorrhage
location
stroke
Acceso en liña:https://www.jstage.jst.go.jp/article/nmc/65/12/65_2025-0164/_pdf/-char/en
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares